76
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The efficacy of HDDPiW-jSB solution on docetaxel-induced alopecia of rats

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 05 Jul 2023, Accepted 27 Dec 2023, Published online: 05 Jan 2024

References

  • Orăsan MS, Coneac A. Experimental animal models of human Diseases - An effective therapeutic strategy. British Library Cataloguing in Publication. London, UK: IntechOpen Limited, 2018.
  • Demir B, Barutca S. Cancer treatments and alopecia: a systematic review. Turkiye Klinikleri J Intern Med. 2021;6(2):96–104. doi:10.5336/intermed.2021-81828.
  • Kang D, Kim IR, Choi EK, et al. Permanent Chemotherapy-Induced alopecia in patients with breast cancer: a 3-Year prospective cohort study. Oncologist. 2019;24(3):414–420. doi:10.1634/theoncologist.2018-0184.
  • Saraswat N, Chopra A, Sood A, et al. A descriptive study to analyze Chemotherapy-Induced hair loss and its psychosocial impact in adults: Our experience from a tertiary care hospital. Indian Dermatol Online J. 2019;10(4):426–430. doi:10.4103/idoj.IDOJ_471_18.
  • Kocan S, Aktug C, Gursoy A. Who am I?" a qualitative meta-synthesis of chemotherapy-induced alopecia and body image perception in breast cancer patients. Support Care Cancer. 2023;31(4):237. doi:10.1007/s00520-023-07704-8.
  • Mosca L, Ilari A, Fazi F, et al. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resist Updat. 2021;54:100742. doi:10.1016/j.drup.2020.100742.
  • Breed WPM, Van Den Hurk CJG, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss: Scalp cooling potentials and limitations. Expert Rev Dermatol. 2011;6(1):109–125. doi:10.1586/edm.10.76.
  • Dykes DJ, Bissery MC, Harrison SD, Jr, et al. Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, taxotere). Invest New Drugs. 1995;13(1):1–11. doi:10.1007/BF02614214.
  • Bissery MC, Nohynek G, Sanderink G, et al. Docetaxel (taxotere): a review of preclinical and clinical experience. Part I: preclinical experience. Anticancer Drugs. 1995;6(3):339–355. doi:10.1097/00001813-199506000-00001.
  • Pieniążek A, Czepas J, Piasecka-Zelga J, et al. Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel. Adv Med Sci. 2013;58(1):104–111. doi:10.2478/v10039-012-0063-1.
  • Müller-Röver S, Handjiski B, van der Veen C, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001; Jul117(1):3–15. doi:10.1046/j.0022-202x.2001.01377.x.
  • Zhang Y, Ni C, Huang Y, et al. Hair growth-Promoting effect of resveratrol in mice, human hair follicles and dermal papilla cells. Clin Cosmet Investig Dermatol. 2021;14:1805–1814. doi:10.2147/CCID.S335963.
  • Saleh D, Nassereddin A, Cook C, Anagen effluvium. StatPearls; 2022.
  • Ferreira MN, Ramseier JY, Leventhal JS. Dermatologic conditions in women receiving systemic cancer therapy. Int J Womens Dermatol. 2019;5(5):285–307. doi:10.1016/j.ijwd.2019.10.003.
  • Calhoun EA, Welshman E, Brown S. Taxane-induced alopecia: a historical review of patients with ovarian or breast cancer treated with paclitaxel, docetaxel or paclitaxel poliglumex. JCO. 2005;23(16_suppl):8044–8044. doi:10.1200/jco.2005.23.16.
  • Nabholtz JM, Mackey JR, Smylie M, et al. Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer. J Clin Oncol. 2001;19(2):314–321. doi:10.1200/JCO.2001.19.2.314.
  • Almohanna HM, Ahmed AA, Tsatalis JP, et al. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb)). 2019;9(1):51–70. doi:10.1007/s13555-018-0278-6.
  • Hidalgo M, Rinaldi D, Medina G, et al. A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. Anticancer Drugs. 1999;10(4):393–395. doi:10.1097/00001813-199904000-00007.
  • Aiba T, Kono Y, Etoh T, et al. Efficacy of cooling therapy and α-lipoic acid derivative against chemotherapy-induced alopecia in an animal model. Cancer Sci. 2023;114(3):1007–1014. doi:10.1111/cas.15639.
  • Stettler H, Kurka P, Wagner C, et al. A new topical panthenol-containing emollient: Skin-moisturizing effect following single and prolonged usage in healthy adults, and tolerability in healthy infants. J Dermatolog Treat. 2017;28(3):251–257. doi:10.1080/09546634.2016.1218417.
  • Kutlu O, Metin A. Systemic dexpanthenol as a novel treatment for female pattern hair loss. J Cosmet Dermatol. 2021;20(4):1325–1330. doi:10.1111/jocd.13729.
  • Geueke A, Mantellato G, Kuester F, et al. The anti-apoptotic bcl-2 protein regulates hair follicle stem cell function. EMBO Rep. 2021;22(10):e52301. doi:10.15252/embr.202052301.
  • Jang H, Jo Y, Lee JH, et al. Aging of hair follicle stem cells and their niches. BMB Rep. 2023;56(1):2–9. doi:10.5483/BMBRep.2022-0183.
  • Botchkareva NV, Ahluwalia G, Shander D. Apoptosis in the hair follicle. J Invest Dermatol. 2006;126(2):258–264. doi:10.1038/sj.jid.5700007.
  • Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene. 2008;27(48):6194–6206. doi:10.1038/onc.2008.297.
  • Kim MH, Kim SH, Yang WM. Beneficial effects of astragaloside IV for hair loss via inhibition of fas/fas L-mediated apoptotic signaling. PLoS One. 2014;9(3):e92984. doi:10.1371/journal.pone.0092984.
  • Shin JY, Kim J, Choi YH, et al. Dexpanthenol promotes cell growth by preventing cell senescence and apoptosis in cultured human hair follicle cells. Curr Issues Mol Biol. 2021;43(3):1361–1373. doi:10.3390/cimb43030097.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.